Sai Life Sciences kicks off FY27 on strong note; Q1 profit jumps 22%
Revenue from operations rose 12% YoY to Rs. 554 crore
Revenue from operations rose 12% YoY to Rs. 554 crore
Sumitomo Pharma says the report contains assertions about its operations and accounting that are “clearly inconsistent with the facts
Beyond water quality monitoring, E-Eye can also analyse toxicants in environmental and biological samples, vegetables, food products, tea, herbal products, soil and milk
The event also celebrated healthy ageing through a vibrant fashion show featuring senior citizens, who showcased confidence, elegance, and enthusiasm
Hikal’s Pharmaceuticals business continued its recovery trajectory, contributing 58% of consolidated revenue, with revenue rising to Rs. 233 crore, a growth of 15.2% YoY
As part of the collaboration, Gland Pharma will establish a dedicated sterile manufacturing suite for APIs used in microparticle depot products at its JNPC facility in Visakhapatnam
The company posted a 25.2% increase in net profit to Rs 1,032 crore, while EBITDA rose 20% year-on-year to Rs 1,924 crore, with EBITDA margin improving 60 basis points to 21.0%
Expects strong H2 recovery on secured orders and pipeline growth
Moderna expanded its global commercial footprint during the quarter through new partnerships, supply agreements and regulatory approvals
The life sciences and diagnostics company posted second-quarter revenue of $730 million
Pharmaceuticals sales were broadly stable at €4.46 billion, supported by continued strong demand for Bayer's newer growth products
The Wegovy franchise remains the leading branded obesity medication in the US market
PAT grows 12% to Rs. 173 crore as US formulations jump 49%; company receives 10 ANDA approvals
To support future CDMO opportunities, the company is expanding manufacturing capacity in phases, with plans to increase capacity to 1,200 KL by FY30
43 pharma units approved under RPTUAS; two common facility projects sanctioned in Solan
Subscribe To Our Newsletter & Stay Updated